JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tachibana, H.
Right arrow Articles by Yamada, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tachibana, H.
Right arrow Articles by Yamada, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 8, 5927-5933, February 25, 2000


Induction of Light Chain Replacement in Human Plasma Cells by Caffeine Is Independent from Both the Upregulation of RAG Protein Expression and Germ Line Transcription*

Hirofumi TachibanaDagger , Hirotaka Haruta, Kyoko Ueda, Takanori Chiwata, and Koji Yamada

From the Division of Bioresources and Bioenvironmental Science, Graduate School, Kyushu University, Hakozaki 6-10-1, Higashi-ku, Fukuoka, 812-8581, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

When some human plasma cell lines are cultured with concanavalin A, the original light chain is replaced with another light chain which results from secondary VJ recombination (light chain shifting). We examined various intracellular factors involved in the induction of light chain shifting. Light chain shifting can be induced upon treatment with agents with phosphatase inhibitory activity such as caffeine and okadaic acid. Although the plasma cells used express both RAG-1 and RAG-2, the expression level of these proteins was not affected by caffeine or okadaic acid. Transcription of the germ line locus, which correlates to the locus activation for rearrangement, is also not influenced by phosphatase inhibition. However, the amount of signal broken-ended DNA intermediates generated during V(D)J rearrangement was shown to increase upon caffeine or okadaic acid treatment. The inhibitory activity of caffeine on phosphatase was the same as okadaic acid. However, caffeine exhibited much higher activity for VJ coding joint formation than okadaic acid. Therefore, although phosphatase inhibition might act, in part, on a mechanism by which V(D)J recombinase activity is regulated within the human plasma cells, other factor(s) are probably also involved in the process.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Immunoglobulin genes are assembled during B cell development through a series of site-specific recombination events collectively termed V(D)J recombination (1). The V(D)J recombination reaction is initiated by the recombination activating gene products RAG-1 and RAG-2 and is completed by a set of proteins employed in most cell types for DNA double-stranded break repair such as the Ku-80 antigen, a large catalytic subunit of DNA-dependent protein kinase and XRCC4 (2-6). Although many of the VJ recombinations at the light chain loci occur in pre-B cells, recent findings suggest that light chain gene rearrangements often continue in immature-B cells and germinal center B cells (7-11). We also have shown that secondary VJ recombination can occur in some human plasma cell lines when stimulated with concanavalin A (ConA)1 (12, 13). We call this process light chain shifting (14).

Several factors have been shown to be involved in Ig gene rearrangement in terms of timing and placement (1). V(D)J recombinase activity is determined by the regulated expression of RAG-1 and RAG-2 (3). These genes are expressed only when B cells rearrange the Ig heavy and light chain loci. The RAG gene products are necessary for Ig recombination, and coexpression of these two genes in nonlymphoid cells is sufficient to confer the ability to recombine artificial plasmid substrates (15). Secondary VJ rearrangements in immature B cells and our plasma B cells are closely correlated with coexpression of the two RAG genes (10, 14). However, there must be additional levels of regulation to determine which loci are targeted for recombination in developing lymphocytes, because endogenous Ig genes are only targeted for complete rearrangement in B lineage cells, and endogenous T cell receptor genes are only completely rearranged in T lineage cells. Plus we have also found that enhancement of RAG expression is not sufficient to induce secondary VJ rearrangement in light chain shifting-inducible human plasma cells (13, 14). Therefore, expression of RAG-1 and RAG-2 is likely to be only part of the mechanism by which V(D)J recombination is activated in lymphoid cells. In lymphoid cells, specific developmental signals result in changes in the chromatin that allows the recombinase access to particular gene segments (16, 17). Results showing that activation of a locus for rearrangement correlates with the transcription of that particular germ line locus support the accessibility hypothesis (18-20).

In this report, we investigated various intracellular factors that may induce light chain shifting in human plasma cells. We found that the RAG gene products and the transcription of the germ line locus is not sufficient to carry out secondary VJ recombination in human plasma cells. However, phosphatase inhibition by caffeine or okadaic acid was found to be necessary to induce secondary VJ recombination. The phosphatase inhibition induced the formation of signal broken-ended DNA intermediates in the cells, which is an initial step in the V(D)J recombination process.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents-- Caffeine, dibutyryl cAMP (DbcAMP), forskolin, ionomycin, H-89, H-7, phorbol myristate acetate (PMA), were obtained from Sigma. Okadaic acid and sodium orthovanadate (vanadate) were purchased from Wako (Osaka, Japan).

Cells and Cell Stimulation-- Fusing a B lymphocyte with the IgM secreting human plasma line NAT-30 (21, 22) generated the human hybridoma cell line HB4C5, which secretes a monoclonal antibody specific to the human histone H2B. For cell stimulation, cells (1 × 106 cells/ml) were cultured in the presence of caffeine (2 mM), DbcAMP (50 ng/ml), forskolin (100 µM), ionomycin (250 ng/ml), H-89 (20 µM), H-7 (100 µM), PMA (50 ng/ml), okadaic acid (1, 10, or 100 nM), or vanadate (100 µM).

Protein Phosphatase Activity Assay-- The protein phosphatase activity in inhibitor-treated cells was assayed using a serine/threonine protein phosphatase assay kit from Upstate Biotechnology according to the manufacturer's instruction. The cells were incubated with caffeine (2 mM), okadaic acid (1 and 100 nM), or vanadate (100 µM) for 24 h in cell culture dishes. At the end of the incubation period, 1 × 106 cells were transferred into Eppendorf tubes, washed with 50 mM Tris/HCl, pH 7.0, and the cells were lysed in 1 ml of extraction buffer (50 mM Tris/HCl, pH 7.0, 0.1% 2-mercaptoethanol, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM phenylmethylsufonyl fluoride, 0.5% Triton X-100). The lysate was spun down at centrifuged for 5 min at 10,000 × g at 4° C, and then the supernatant was recovered. 20 µl of the supernatant was mixed with 5 µl of 1 mM phosphatase substrate (phosphopeptide; K-R-pT-I-R-R), the mixture was incubated for 60 min at 37 °C. 100 µl of Malachite Green solution was added to the mixture to terminate the enzyme reaction, and then the mixture was incubated at room temperature for 15 min to allow color development. Absorbance at 650 nm was measured, and phosphatase activity was calculated by comparing the absorbance to the phosphate standard curve.

Western Blot Analysis of RAG and lambda  Light Chain Expression-- Cells were collected, washed once in phosphate-buffered saline, lysed in 60 mM Tris/HCl, pH 7.6, 1% SDS, and boiled for 5 min. Protein concentration was determined using the Bio-Rad protein assay kit, and lysates (600 µg/sample) were electrophoresed on SDS-polyacrylamide gels (10%) and then transferred to a nitrocellulose membrane. The blotted RAG proteins were detected by immunoblotting with 1 µg/ml of anti human RAG-1 or RAG-2 antibodies (Pharmingen, San Diego, CA). Immunoreactive proteins were detected by incubation with horseradish peroxidase-conjugated goat anti mouse IgG antibody (Sigma) at a 1:2000 dilution for 1 h at room temperature; immobilized horseradish peroxidase was visualized using an enhanced chemiluminescence assay (Amersham Pharmacia Biotech). To detect the human lambda  light chain, the blotted membrane was incubated in a 1:500 dilution of horseradish peroxidase-conjugated goat anti-human lambda  light chain antibody (BIOSOURCE) for 1 h. The membranes were washed in phosphate-buffered saline containing 0.05% Tween 20 and developed with 1.6 mM 4-chloro-1-naphthol, 0.01% H2O2 in phosphate-buffered saline with 20% methanol.

RT-PCR and Nucleotide Sequence Analysis-- Total RNA, prepared using the TRIzol reagent (Life Technologies, Inc.), was reversed transcribed, and the resultant cDNA served as a template for PCR amplification using specific primers. cDNA was synthesized from total RNA using a kit (Amersham Pharmacia Biotech) according to the instructions provided by the manufacturer. To synthesize the cDNA from the Vlambda 6 germ line transcript, 20 pmol each of P-Vlambda CA3GTR (5'-GGAGTTTCTGTCTCACTTCC-3') and P-G3PDR (5'-GGATGATGTTCTGGAGAGCC-3') were used for reverse transcription. Glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH) amplification was carried out and used as a control standard. As a negative control, mRNA samples that were not reverse-transcribed also served as templates for PCR amplification. PCR was done in 50-µl reaction volumes containing 10 mM Tris/HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 20 µg/ml gelatin, 1 µM of each primer, 0.2 mM of each dNTP, and 1 unit of Taq polymerase (Fermentas, Lithuania). Samples were predenatured at 94 °C for 2 min followed by amplification at 96 °C for 20 s, 60 °C for 1 min, and 72 °C for 1 min followed by a final 10-min extension step at 72 °C. The number of cycles for amplification of the variable region of lambda  chain, GAPDH gene, or Vlambda 6 germ line transcript was 20, 10, or 12, respectively. The PCR primers used were as follows. The V regions of the lambda  light chain genes (23): P-LLF, 5'-ACTAGAATTCATG(AG)CCTG(CG)(AT)C(CT)CCTCTC(CT)T(CT)CT(CG)(AT)(CT)CC-3'; P-LLR, 5'-ACTAGCGGCCGCCTATGAACATTC(CT)G(CT)AGGGGC-3'; GAPDH, P-GAPDF, 5'-CATCACCATCTTCCAGGAGC-3'; and P-GAPDR, 5'-GGATGATGTTCTGGAGAGCC-3'. The nucleotide sequences of the V region were determined, after subcloning into the pGEM-T vector (Promega), using the DyeDeoxy terminator kit (Perkin-Elmer) with the DNA sequencer ABI 310 (Perkin-Elmer) according to the manufacturer's instruction.

DNA Analysis-- Genomic DNA was prepared as described previously (19). The PCR was performed to detect the Vlambda C5-to-Jlambda coding joint for the original lambda  light chain lambda C5 or the Vlambda Jlambda coding joints for the new lambda  light chains (FF1, FF2, and FF3). The following primers were used: Vlambda 4P (Vlambda 4-CDR1 region-specific) 5'-CTCTGAGCAGTGGGCACAGC-3' (sense), Vlambda 6P (Vlambda 6-CDR1 region-specific) 5'-AGTTGCAGCATTTTCAGCAAC-3' (sense), and Jlambda P (conserved 3' of Jlambda ) 5'-TCAGTTTAGTCCCTCCGCC-3' (antisense). PCR reactions were done as described above for RT-PCR. Aliquots were withdrawn at cycles 20 and 25 for separate analysis to ensure that amplification was within a linear range. Reaction products were run on 0.8% agarose gels, followed by Southern blot hybridization. The PCR products were transferred onto nylon transfer membranes (Hybond-N+, Amersham Pharmacia Biotech), and hybridized with fluorescein-labeled probes. cDNA fragments coding for each lambda  light chain, which were used for analyzing the variable region sequence, was digested from their respective vectors with restriction enzymes. The resulting fragment, each containing the specific V gene, was labeled using the oligonucleotide labeling kit (Gene Images, Amersham Pharmacia Biotech) for use as probes for the detection of the corresponding Vlambda Jlambda coding joints. To check for possible Taq polymerase errors, all PCR products were sequenced and compared with previously defined sequences.

LMPCR Assay for Detecting Signal DNA Broken Ends (SBE)-- The LMPCR assays for detecting signal end breaks, as have been described by Schlissel et al. (24), was performed with minor modifications. The BW linker was made by annealing the oligonucleotides BW-1 (5'-GCGGTGACCCGGGAGATCTGAATTC-3') and BW-2 (5'-GAATTCAGATC-3'). 2 µg of genomic DNA extracted as described above were ligated with 20 pmol of the BW linker in a reaction volume of 20 µl using 3 units of T4 DNA ligase (Promega). The same reaction mixtures without the BW linker were also prepared as negative controls. After an overnight incubation at 4 °C, the ligation reaction was stopped by incubating samples at 95 °C for 10 min. Hot start PCR amplification was performed in a 10-µl reaction volume using 0.5 unit of Taq DNA polymerase (AmpliTaq Gold, Perkin Elmer), 10 pmol each of the sense direction primer BW-1 and the antisense direction primer P-Vlambda 6SBER (5'-CTTAGTAGCTGAAGACATGC-3'), and 1 µl of serially diluted linker-ligated templates. Samples were predenatured at 95 °C for 9 min followed by 35 cycles of 96 °C for 20 s, 62 °C for 10 s, and 72 °C for 30 s followed by a final 7-min extension step at 72 °C. After amplification, bands for Vlambda 6 SBE were detected by Southern hybridization. Blots were visualized using the fluorescein-labeled locus-specific internal probe P-Vlambda CA3GTR.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Induction of New lambda  Light Chain Production in the Plasma B Cell Line HB4C5 by Caffeine Stimulation-- We previously found that ConA simulation can induce light chain replacement in the human plasma cell line HB4C5, which is known to secrete IgM reactive to the human histone H2B (22). This lectin is known to have a multitude of effects in mammalian systems (25, 26). To elucidate which intracellular factors are involved in the light chain shifting, we tested various agents that affect second messenger pathways for their influence on new light chain production in the HB4C5 cells. The HB4C5 cells were cultured in medium containing caffeine, DbcAMP, forskolin, ionomycin, H-89, H-7, or PMA for 2 weeks. Then, the culture supernatants were analyzed for the secretion of lambda  light chains by immunoblotting (Fig. 1). Among the compounds that increase intracellular cAMP concentration, caffeine, DbcAMP, and forskolin, only caffeine was shown to be able to induce the expression of a new lambda  light chain. Furthermore, H-89 and H-7 (inhibitors of serine/threonine protein kinase), ionomycin (known to increase free cytosolic calcium concentration), and PMA (known to stimulate protein kinase C) failed to induce the production of a new light chain. These results suggest that induction of the new lambda  light chain by ConA can be mimicked by treatment with caffeine, whereas several other known factors that affect second messenger pathways cannot.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Induction of new lambda  light chain production in the human plasma cell line HB4C5 by caffeine stimulation. Culture supernatants from HB4C5 cells cultured for 2 weeks in the presence of caffeine (2 mM), DbcAMP (50 ng/ml), forskolin (100 µM), ionomycin (250 ng/ml), H-89 (20 µM), H-7 (100 µM), or PMA (50 ng/ml) were analyzed for the secretion of lambda  light chains by immunoblotting.

To confirm that the caffeine-induced new light chain production is a result from light chain shifting, we subcloned the caffeine-treated cells. One of the feature of light chain shifting is that new light chain-secreting subclones produce only one new light chain replacing the originally expressed light chain. Culture supernatants from 68 subclones, which were cloned by limiting dilution, were selected randomly from caffeine-treated HB4C5 cells and subjected to SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose, and lambda  light chains were detected using an anti human lambda  light chain antibody (Fig. 2). Secretion of the various new lambda  light chains, which are determined by their difference in size from the original (32 kDa), was observed in 8 wells (Fig. 2, lanes 7, 34, 35, 36, 40, 49, 56, and 57). Three independent subclones (FF1, FF2, and FF3) that were shown to secrete not the original lambda  chain but only a new lambda  chain were selected, and nucleotide sequences of the variable regions of these expressed light chains were analyzed (Fig. 3). Sequences were compared with the corresponding germ line Vlambda (HUMIGL8V and HSIGLV36). The germ line Vlambda gene of the original lambda  light chain (lambda C5) has been shown to belong to Vlambda 1 family, as grouped by Chuchana et al. (27). The germ line Vlambda families used in the light chain genes from the three subclones were shown to be Vlambda 4 and Vlambda 6. Strikingly, these Vlambda gene families are the least frequently used (28). Although FF2 and FF3 express genes encoded by the same germ line Vlambda gene (HSIGLV36), they apparently originated from independent recombination events, as judged by having distinct VJ joining sequences. This was confirmed by a genomic DNA analysis using Vlambda family-specific probes (Fig. 4). The same expression pattern for new light chains was also found in ConA-induced light chain shifting, suggesting that caffeine stimulation does indeed induce the light chain shifting.


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 2.   Immunoblot analysis of secretion of a new light chain replacing the originally expressed light chain from caffeine-treated cells. Culture supernatants from 68 subclones, which were cloned by limiting dilution, were selected randomly from caffeine-treated HB4C5 cells, subjected to SDS-polyacrylamide gel electrophoresis, and transferred to nitrocellulose, and lambda  light chains were detected using an anti human lambda  light chain antibody/horseradish peroxidase conjugate.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   Nucleotide sequences of the variable regions for the new lambda  light chains expressed in light chain-shifted subclones. Nucleotide sequences of the variable regions for the light chains expressed in the three HB4C5 subclones (FF1, FF2, and FF3) are shown in a 5' to 3' direction. VLFF1, VLFF2, and VLFF3 represent the lambda  light chain genes expressed by these subclones. Sequences were compared with the corresponding germ line Vlambda (HUMIGL8Vand HSIGLV36) and Jlambda 2/3 sequences. Designations in brackets indicate their corresponding Vlambda gene family. Dashes indicate homology with the germ line genes. Dots indicate where gaps have been introduced to maximize homology.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Expression of new light chains induced by caffeine is a result of secondary VJ rearrangements. a, a diagram of the PCR primers used to detect the VJ coding joint. The directions of primers used are indicated with arrowheads. b, genomic DNA from HB4C5 cells and the new light chain-expressing subclones FF1, FF2, and FF3 were analyzed for secondary VJ rearrangement by PCR. The PCR amplified products were detected with the Vlambda 4- and Vlambda 6-specific probes. Bands corresponding to the VJ coding joint for Vlambda 4 joined to Jlambda and Vlambda 6 jointed to Jlambda are shown. c, genomic DNA from HB4C5 cells treated with caffeine (2 mM), DbcAMP (50 ng/ml), forskolin (100 µM), ionomycin (250 ng/ml), H-89 (20 µM), H-7 (100 µM), PMA (50 ng/ml), or PMA (50 ng/ml) + ionomycin (250 ng/ml) were also analyzed for secondary Vlambda 6-Jlambda rearrangement.

Caffeine-stimulated New Light Chain Expression Is a Result of Secondary VJ Rearrangements-- To determined whether the new light chain expression stimulated by caffeine results from secondary recombination, we analyzed Vlambda Jlambda gene rearrangements in the new light chain-expressing subclones, FF1, FF2, and FF3. Genomic DNA from HB4C5 cells and the FF1, FF2, and FF3 subclones was subjected to PCR to detect for the presence of a Vlambda Jlambda coding joint formation specific for the new light chain using primers corresponding to the Vlambda 4 and Vlambda 6 families. The products were analyzed by Southern blot hybridization. A diagram of the PCR assay is shown in Fig. 4a. PCR product was detected only in the DNA from the new light chain-producing subclones, suggesting that the new VJ rearrangements occurred during the cell stimulation with caffeine (Fig. 4b). In Fig. 1, we tested various agents for their ability to secrete a new light chain and found that only caffeine could stimulate new light chain production. We tested the same agents for their ability to induce secondary VJ recombination by PCR using the Vlambda 6P and Jlambda P primers. Only caffeine activated the secondary VJ recombination (Fig. 4c), which supports the results in Fig. 1. These genetic events in the caffeine-stimulated new light chain-producing cells exactly match the results shown for ConA-stimulated cells, suggesting that caffeine does mimic the effect of ConA stimulation on the light chain shifting.

Caffeine-induced Secondary VJ Recombination in Plasma Cells Depends on Phosphatase Inhibitory Activity-- Caffeine exerts a multitude of effects in mammalian cells including DNA intercalation and inhibition of protein serine/threonine phosphatase and cAMP phosphodiesterase (29-31). As shown previously, with the exception of caffeine, agents that increase intracellular cAMP could not induce light chain shifting. Interestingly, HB4C5 cells costimulated with caffeine and DbcAMP did not express any new light chains (data not shown). Thus, effects other than the increasing of cAMP are thought to be responsible for the induction of the light chain shifting by caffeine.

To test the possibility that the effect of caffeine on light chain shifting is due to serine/threonine protein phosphatase inhibitory activity, HB4C5 cells were treated with okadaic acid, which is a serine/threonine phosphatase inhibitor (32), or vanadate, which is an inhibitor of dual specificity phosphatase and tyrosine phosphatase (33). Genomic DNA was analyzed for the formation of a VJ coding joint by PCR, as described in the legend to Fig. 4. We focused on the Vlambda 6-to-Jlambda coding joint formation because it is the most frequently used Vlambda segment in light chain shifting. As shown in Fig. 5a, stimulation of HB4C5 cells with okadaic acid at a concentration of 100 nM for 96 h induced the formation of a Vlambda 6-to-Jlambda coding joint. Similar induction levels of the VJ recombination was obtained even at lower concentrations (10 and 1 nM). In contrast, a concentration of 100 µM vanadate was less efficient for the induction of VJ recombination. To determine the inhibitory effects of these agents on the serine/threonine protein phosphatase in HB4C5 cells, the phosphatase activity in the cells treated with either the agent or caffeine was measured (Fig. 5b). Caffeine treatment decreased serine/threonine phosphatase activity by 10%. Treatment with okadaic acid or vanadate also caused a 10-20% loss of the phosphatase activity. Therefore, the induction of light chain shifting may be brought about, in part, by the inhibition of serine/threonine protein phosphatase. However, the level of VJ coding joint formation by caffeine was much higher than that by okadaic acid and vanadate. Therefore, other factor(s) may be involved in the process.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 5.   Induction of secondary VJ recombination in the plasma cell line HB4C5 by phosphatase inhibitors. a, genomic DNA was analyzed for secondary VJ rearrangement by PCR. A diagram of the PCR primers used to detect the formation of new VJ coding joint is shown in Fig. 4a. PCR was performed using primers that amplify the Vlambda 6-Jlambda coding joint formation with diluted (100 and 10 ng) total genomic DNA taken from HB4C5 cells treated with caffeine (2 mM), okadaic acid (1, 10, 100 nM), or vanadate (100 µM) for 96 h. The PCR amplified products were detected using the Vlambda 6-specific probe by Southern blotting. GAPDH gene amplification was simultaneously performed as a DNA loading control. b, the cells were treated with caffeine (2 mM), okadaic acid (1 nM, 100 nM), or vanadate (100 µM) for 24 h. The serine/threonine protein phosphatase activity was detected as described under "Materials and Methods" and expressed as a percentage of the control level (assuming the sample obtained from the nontreated cells has an activity of 100%).

RAG Protein Expression and Germ Line lambda  Gene Transcription Are Not Enhanced by Caffeine or Okadaic Acid-- RAG-1 and RAG-2 gene products have been shown to be essential for initiating Ig gene rearrangement, and the levels of the RAG proteins have been known to be affected with cell proliferation (2, 24). Both proteins were expressed in the HB4C5 cells (13). To elucidate the mechanism that couples phosphatase inhibition and light chain shifting, we evaluated the expression of RAG genes in the HB4C5 cells. The level of RAG proteins expressed was not affected by the stimulation of either caffeine or okadaic acid at the concentration sufficient for inducing light chain shifting (Fig. 6). We also found no differences in the growth rates and viability of the cells stimulated with or without these agents (data not shown). Thus, the induction of light chain shifting by these agents seems to be independent from the enhancement of RAG gene expression.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Induction of secondary VJ rearrangement by phosphatase inhibitors does not result from an enhancement of RAG protein expression. Cells were stimulated with the indicated stimuli for 24 and 96 h (unstimulated control, 2 mM caffeine, 1 nM okadaic acid). Cells were lysed in SDS lysis buffer. 600 µg protein/lane from each sample was fractionated by 10% SDS-polyacrylamide gel electrophoresis, and the expression of RAG-1 and RAG-2 proteins was assessed by immunoblotting.

It has been shown that genes undergoing V(D)J recombination are transcribed coincident with or before their rearrangement (34), and an increase in the production of the germ line transcript is associated with gene rearrangement (35). These observations have led to the hypothesis that stimuli by caffeine or okadaic acid can induce light chain shifting via an enhancement of germ line transcription. Because the Vlambda 6 locus is frequently used in light chain shifting, we used the unrearranged Vlambda 6 locus as a model Vlambda gene segment to test this possibility (14). RT-PCR used to detect and quantify the amount of transcript produced. We found that the HB4C5 cells could transcribe the germ line Vlambda 6 locus at any of the given time points tested (Fig. 7). The steady-state levels of the transcript did not changed upon treatment with caffeine or okadaic acid for 3, 6, 24, and 96 h (Fig. 7, b and c). These results indicate that incubation with the phosphatase inhibitors do not affect the germ line transcription in HB4C5 cells. The failure to observe an increase in germ line gene transcription as well as RAG protein expression, both of which are known to parallel the increase in frequency of V(D)J recombination, leads us to suggest that other factor(s) may be involved when light chain shifting is induced upon stimulation with caffeine or okadaic acid.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 7.   Detection of the Vlambda germ line transcript in HB4C5 cells treated with phosphatase inhibitors. a, schematic diagram of the Vlambda 6 390-bp RT-PCR product. b and c, Vlambda 6 germ line and GAPDH gene transcripts were evaluated by quantitative RT-PCR followed by Southern blotting. RNA isolated from the cells treated as indicated (2 mM caffeine or 1 nM okadaic acid) for 0, 3, 6, or 24 h (b) and 96 h (c) was assayed. Serially diluted (50, 5, or 0.5 ng of total RNA equivalent) cDNA were used as templates in this assay. The same samples were also used as templates for amplification of GAPDH followed by Southern hybridization as a DNA loading control. As a negative control, mRNA samples (100 ng of total RNA equivalent) were isolated from cells treated with either caffeine or okadaic acid for 24 h. These non-reverse-transcribed samples were used as templates for PCR (indicated as -RT). The arrows indicate the expected size for each PCR product.

The Amount of Signal Broken Ends Derived from the Initiation of lambda  Chain Gene Rearrangement Is Increased by Phosphatase Inhibition-- V(D)J recombination is initiated by a precise cleavage at the junction between a coding gene and a flanking recombination signal sequence to generate two broken-ended species, a signal end, and a coding end (cutting phase). The signal ends and coding ends are subsequently joined to generate signal joints and coding joints (joining phase) (36). We investigated whether the two phases are enhanced upon stimulation with the phosphatase inhibitors. SBE are in a blunt-ended conformation until they are joined, and this broken-ended species is joined before the onset of DNA synthesis (24, 37). Thus, in cycling cells, SBE can be a reliable measure of VJ recombinase activity. If the cutting phase of V(D)J recombination is activated by stimulation with caffeine or okadaic acid, the amount of SBE produced might increase (38). Genomic DNA prepared from HB4C5 cells stimulated with one of the phosphatase inhibitors for 24 and 96 h was assayed for SBE using LMPCR (24). DNA were subjected to ligation with a double-stranded linker capable of ligating in only one orientation. Linker-ligated DNA was then used as template for amplification by PCR using a linker-specific primer and a locus-specific primer (Fig. 8a). The same experiment using independently prepared genomic DNA samples were performed several times, and a representative result is shown. HB4C5 cells after cultivation with caffeine or okadaic acid for 96 h contain a definitely higher level of Vlambda 6 SBE compared with unstimulated cells (Fig. 8c), whereas the SBE signal was barely detected in the DNA obtained from the cells treated with these agents for 24 h (Fig. 8b). These results shows that at least early steps in the Vlambda -Jlambda recombination are enhanced in HB4C5 cells stimulated by agents with phosphatase inhibitory activity.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 8.   LMPCR analysis of signal end double-stranded DNA breaks in Vlambda Jlambda recombination. a, diagram of the LMPCR assay used to detect signal end double-stranded DNA breaks on the rearranging loci. A pair of annealed oligonucleotides (thick bar) is ligated to signal end present in DNA prepared from the cells. PCR was performed using appropriate primers (BW1 and P-Vlambda 6 SBER). b and c, genomic DNA, extracted from HB4C5 cells cultured with the stimuli indicated above each lane for 24 h (b) and 96 h (c) were ligated with (linker (+)) or without (linker (-)) the BW linker, and were subjected to PCR to detect SBE. 100 and 10 ng of genomic DNA equivalent samples ligated with the BW linker were prepared and used as templates. PCR products were probed with an internal locus-specific oligonucleotide probe (P-Vlambda CA3GTR). Bands for Vlambda 6 SBE were expected to be 497 bp in length, and the positions are indicated by the arrows. GAPDH gene amplification followed by Southern hybridization using the same samples for detection of Vlambda 6 SBE was simultaneously performed as a DNA loading control.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We have previously found that the lambda  light chain replacement from an original to a novel chain can be induced in some human plasma cells by ConA stimulation (12, 13). We call this process light chain shifting. This finding is in contrast to reports stating that continuous novel light chain expression can occur in some sIg+ B cells in vitro and in vivo but not in Ig-secreting plasma cells (7-11). In the current study, we address the mechanism by which light chain shifting occurs in some human plasma cells. To elucidate the intracellular factors involved in light chain shifting, we tested agents that affect second messenger pathways, which can induce light chain shifting in the human plasma cell line HB4C5. Several agents that stimulate protein kinase C, increase intracellular cAMP and calcium, and inhibit protein kinase A did not mediate the induction of light chain shifting. We found that light chain shifting can be induced by caffeine. However, other agents that also can increase intracellular cAMP concentration, DbcAMP and forskolin, could not induce light chain shifting. Therefore, the induction of light chain shifting is thought to be independent of intracellular cAMP, and other effect(s) of caffeine should be considered to be responsible for the induction of the light chain shifting.

Caffeine has pleiotoropic effects in mammalian cells, for example DNA intercalation and inhibiting poly(ADP-ribose) polymerase, cAMP phosphodiesterase, and serine/threonine phosphatases (29-31). To test the possibility that the effect of caffeine on light chain shifting is due to the inhibition of phosphatase activity, HB4C5 cells were treated with okadaic acid, which is a serine/threonine phosphatase inhibitor (32), or vanadate, which is an inhibitor of dual specificity phosphatase and tyrosine phosphatase (33). Okadaic acid was able to induce secondary VJ rearrangement in the HB4C5 cells upon stimulation with a 1 nM dose, which is equivalent to IC50 for type 2A and 4 serine/threonine phosphatase and much lower than type 1 and type 2B (39). Conversely, vanadate was less efficient for the induction of the VJ recombination. These results suggest that at least the inhibition of type 2A and/or type 4 serine/threonine protein phosphatase may play a role in the induction of light chain shifting. More study is necessary to elucidate how this inhibition affects light chain shifting in HB4C5 cells. The role of phosphorylation in the control of recombination has only been shown for the expression of RAG proteins, which are critical for initiating the V(D)J recombination (2). RAG-2 protein is marked for degradation upon phosphorylation by p34cdc2 kinase (40). It has been shown that p34cdc2 kinase can be activated by caffeine (41, 42), suggesting that caffeine may act as an agent in the degradation pathway of RAG-2 protein. In fact, the expression of RAG proteins was not enhanced in the HB4C5 cells when stimulated with caffeine or okadaic acid. We have previously shown that the enhancement of RAG gene expression did not induce the light chain shifting (13). Taken together, these results suggest that the induction of light chain shifting in plasma cells by caffeine is not due to an enhancement of the RAG gene expression.

V(D)J recombination of the Ig genes is initiated by the RAG-1 and RAG-2 proteins, which recognize the recombination signal sequences that flank each V, D, and J segment, to introduce double-stranded DNA breaks between the gene segments and the recombination signal sequence, resulting in signal broken ends and coding broken ends (cutting phase). The joining of recombination signal sequence and coding ends relies on generally expressed cellular factors involved in DNA double-stranded break repair (43). RAG gene expression and germ line transcription are thought to be sufficient enough for activating the cutting phase. Even though HB4C5 cells do produce the germ line transcript, the expression level of Vlambda germ line transcript in HB4C5 cells did not change when stimulated with caffeine or okadaic acid. This suggests that the occurrence of secondary Vlambda Jlambda rearrangement in this plasma cell line is not a result of up-regulation of the Vlambda germ line transcription. Although the level of RAG proteins and Vlambda germ line transcript produced was not affected by the addition of caffeine or okadaic acid, the amount of signal broken end at the Vlambda locus as a result of the action of a V(D)J recombinase clearly increased. This result suggests that the cutting phase in the rearrangement process can be activated by caffeine or okadaic acid, and the inability to rearrange the Vlambda Jlambda region in HB4C5 cells in absence of these agents may be due the lack of formation of the Vlambda SBE.

These results demonstrate that factor(s) other than the RAG proteins and the up-regulation of germ line transcription may be involved in the induction of secondary Vlambda Jlambda rearrangement by caffeine or okadaic acid. The recruitment process for the recombinase complex to the rearranging locus remains obscure (17). At least, the increase of Vlambda SBE in HB4C5 cells cultured with caffeine or okadaic acid may reflect a recruitment of a recombinase complex to the Vlambda locus. All known stimuli such as cAMP-raising agents, interleukin-4, and/or lipopolysaccharide, which trigger V(D)J rearrangement in pre-B and mature B cells, induce either RAG gene expression or germ line transcription (9-11, 44, 45). Thus, caffeine may play a unique role in determining other aspects of the initiation mechanism for secondary Vlambda Jlambda rearrangement in human plasma cells.

We observed that SBE is generated at elevated amounts after a 96-h stimulation time period with caffeine but was barely detected after 24 h. This time lag suggests that stimulation for over 24 h is needed before change of the chromatin structure at the light chain locus and/or V(D)J recombinase activation in HB4C5 cells can occur. This supports the hypothesis that activation of the recruitment process, which brings the recombinase complex to the Vlambda locus, is regulated by as yet unknown additional factor(s) that may be up-regulated or activated by the phosphatase inhibitory effect of caffeine or okadaic acid. Determining such factor(s) will be informative in elucidating the regulation mechanism for the light chain shifting in human plasma cells.

The observation that the amount of SBE induced by caffeine is almost equal to that induced by okadaic acid is not consistent with the observation that Vlambda Jlambda coding joint formation induced by caffeine is at a much higher level than that by okadaic acid. This result suggests that the difference in VJ coding joint formation between caffeine and okadaic acid may be correlated with the difference in the activity for joining coding ends and may be mediated by an effect other than phosphatase inhibitory activity of caffeine.

    ACKNOWLEDGEMENT

We thank Perry Seto for proofreading the manuscript.

    FOOTNOTES

* This work was supported in part by Grant-in-Aid for Encouragement of Young Scientists and Program for Promotion of Basic Research Activities for Innovative Biosciences.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. E-mail: tatibana@agr.kyushu-u.ac.jp.

    ABBREVIATIONS

The abbreviations used are: ConA, concanavalin A; DbcAMP, dibutyryl cAMP; PMA, phorbol myristate acetate; vanadate, sodium orthovanadate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; SBE, signal DNA broken end; PCR, polymerase chain reaction; RT, reverse transcriptase; LMPCR, ligation-mediated PCR.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Lewis, S. M. (1994) Adv. Immunol. 56, 27-150[Medline] [Order article via Infotrieve]
2. Oettinger, M. A., Schatz, D. G., Gorka, C., and Baltimore, D. (1990) Science 248, 1517-1523[Abstract/Free Full Text]
3. Schatz, D. G., Oettinger, M. A., and Baltimore, D. (1989) Cell 59, 1035-1048[CrossRef][Medline] [Order article via Infotrieve]
4. Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Sokol, K., Nussenzweig, M. C., and Li, G. C. (1996) Nature 382, 551-555[CrossRef][Medline] [Order article via Infotrieve]
5. Taccioli, G., and Alt, F. W. (1995) Curr. Opin. Immunol. 7, 436-440[CrossRef][Medline] [Order article via Infotrieve]
6. Li, Z., Otevrel, T., Gao, Y., Cheng, H.-L., Seed, B., Stamoto, T. D., Taccioli, G. E., and Alt, F. W. (1995) Cell 83, 1079-1089[CrossRef][Medline] [Order article via Infotrieve]
7. Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993) J. Exp. Med. 177, 999-1008[Abstract/Free Full Text]
8. Tiegs, S., Russell, D. M., and Nemazee, D. (1993) J. Exp. Med. 177, 1009-1020[Abstract/Free Full Text]
9. Papavasiliou, F., Casellas, R., Suh, H., Qin, X.-F., Besmer, E., Pelanda, R., Nemazee, D., Rajewsky, K., and Nussenzweig, M. C. (1997) Science 278, 298-301[Abstract/Free Full Text]
10. Han, S., Dillon, S. R., Zheng, B., Shimoda, M., Schlissel, M. S., and Kelsoe, G. (1997) Science 278, 301-305[Abstract/Free Full Text]
11. Hikida, M., and Ohmori, H. (1998) J. Exp. Med. 187, 795-799[Abstract/Free Full Text]
12. Tachibana, H., Kido, I., and Murakami, H. (1994) J. Biol. Chem. 269, 29061-29066[Abstract/Free Full Text]
13. Tachibana, H., Ushio, Y., Chatchadaporn, K., and Shirahata, S. (1996) J. Biol. Chem. 271, 17404-17410[Abstract/Free Full Text]
14. Tachibana, H., Haruta, H., and Yamada, K. (1999) Blood 93, 198-207[Abstract/Free Full Text]
15. Yancopoulos, G., Blackwell, T., Suh, H., Hood, L., and Alt, F. W. (1986) Cell 44, 251-259[CrossRef][Medline] [Order article via Infotrieve]
16. Stanhope-Baker, P., Hudson, K. M., Shaffer, A. L., Constantinescu, A., and Schlissel, M. S. (1996) Cell 85, 887-897[CrossRef][Medline] [Order article via Infotrieve]
17. Constantinescu, A., and Schlissel, M. S. (1997) J. Exp. Med. 185, 609-620[Abstract/Free Full Text]
18. Yancopoulos, G. D, and Alt, F. W. (1985) Cell 40, 271-281[CrossRef][Medline] [Order article via Infotrieve]
19. Schlissel, M. S., Corcoran, L. M., and Baltimore, D. (1991) J. Exp. Med. 173, 711-720[Abstract/Free Full Text]
20. Schlissel, M. S., and Morrow, T. (1994) J. Immunol. 153, 1645-1657[Abstract]
21. Murakami, H., Hashizume, S., Ohashi, H., Shinohara, K., Yasumoto, K., Nomoto, K., and Omura, H. (1985) In Vitro Cell. Dev. Biol. 21, 593-596[Medline] [Order article via Infotrieve]
22. Kato, M., Mochizuki, K., Kuroda, K., Sato, S., Murakami, H., Yasumoto, K., Nomoto, K., and Hashizume, S. (1991) Hum. Antibod. Hybridomas 2, 94-101[Medline] [Order article via Infotrieve]
23. Larrick, J. W., Danielsson, L., Brenner, C. A., Wallace, E. F., Abrahamson, M., Fry, K. E., and Borrebaeck, C. A. K. (1989) Bio/Technology 7, 934-938[CrossRef]
24. Schlissel, M. S., Constantinescu, A., Morrow, T., Baxter, M., and Peng, A. (1993) Genes Dev. 7, 2520-2532[Abstract/Free Full Text]
25. Ohta, S., Inazu, T., Taniguchi, T., Nagata, G., and Yamamura, H. (1992) Eur. J. Biochem. 206, 895-900[Medline] [Order article via Infotrieve]
26. Wenzel-Seifert, K., Krautwurst, D., Lentzen, H., and Seifert, R. (1996) J. Leukoc. Biol. 60, 345-355[Abstract]
27. Chuchana, P., Blancher, A., Brockly, F., Alexandre, D., Lefranc, G., and Lefranc, M.-P. (1990) Eur. J. Immunol. 20, 1317-1325[Medline] [Order article via Infotrieve]
28. Williams, S. C., Frippiat, J.-P., Tomlinson, I. M., Ignatovich, O., Lefranc, M.-P., and Winter, G. (1996) J. Mol. Biol. 264, 220-232[CrossRef][Medline] [Order article via Infotrieve]
29. Tornaletti, S., Russo, P., Parodi, S., and Pedrini, A. M. (1989) Biochim. Biophys. Acta 1007, 112-115[Medline] [Order article via Infotrieve]
30. Lock, R. B., Galperina, O. V., Feldhoff, R. C., and Rhodes, L. J. (1994) Cancer Res. 54, 4933-4939[Abstract/Free Full Text]
31. Butcher, R. W., and Sutherland, E. W. (1962) J. Biol. Chem. 237, 1244-1250[Free Full Text]
32. Thevenin, C., Kim, S.-J., and Kehrl, J. H. (1991) J. Biol. Chem. 266, 9363-9366[Abstract/Free Full Text]
33. Gordon, J. A. (1991) Methods Enzymol. 201, 477-482[Medline] [Order article via Infotrieve]
34. Schlissel, M. S., and Baltimore, D. (1989) Cell 58, 1001-1007[CrossRef][Medline] [Order article via Infotrieve]
35. Wang, W., Rath, S., Durdik, J. M., and Sen, R. (1998) J. Immunol. 160, 1789-1795[Abstract/Free Full Text]
36. Rajewsky, K. (1996) Nature 381, 751-753[CrossRef][Medline] [Order article via Infotrieve]
37. Ramsden, D. A., and Gellert, M. (1995) Genes Dev. 9, 2409-2420[Abstract/Free Full Text]
38. Roth, D. B., Menetski, J. P., Nakajima, P. B., Bosma, M. J., and Gellert, M. (1992) Cell 70, 983-991[CrossRef][Medline] [Order article via Infotrieve]
39. Hunter, T. (1995) Cell 80, 225-236[CrossRef][Medline] [Order article via Infotrieve]
40. Lin, W. C., and Desiderio, S. (1993) Science 260, 953-959[Abstract/Free Full Text]
41. Hains, J., Crompton, N. E. A., Burkar, W., and Jaussi, R. (1993) Cancer Res. 53, 1507-1510[Abstract/Free Full Text]
42. Yao, S.-L., Akhtar, A. J., McKenna, K. A., Bedi, G. C., Sidransky, D., Mabry, M., Ravi, R., Collector, M. I., Jones, R. J, Sharkis, S. J., Fuchs, E. J., and Bedi, A. (1996) Nat. Med. 2, 1140-1143[CrossRef][Medline] [Order article via Infotrieve]
43. Weaver, D. T., and Alt, F. W. (1997) Nature 388, 428-429[CrossRef][Medline] [Order article via Infotrieve]
44. Menetski, J., and Gellert, M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9324-9328[Abstract/Free Full Text]
45. Hertz, M., Kouskoff, V., Nakamura, T., and Nemazee, D. (1998) Nature 394, 292-295[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar